Search research articles
Contact Us
Filters
Showing results (1451-1460 of 1,472) with videos related to
Page
of 148
Sort By:
Lancet (London, England)
|
November 27, 2018
Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK
Roger Williams, Graeme Alexander, Richard Aspinall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 17, 2025
Association Between Sustained Virological Response and Adverse Liver-related Events in Patients With Decompensated Hepatitis C Virus Cirrhosis
Lisa M van Velsen, Lisette A P Krassenburg, Grishma Hirode, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
Hidden immune memory niches in inflammatory skin diseases
Lloyd Steele, April R Foster, Kenny Roberts, et al.
JAMA
|
December 13, 2022
Effects of Mindfulness Training and Exercise on Cognitive Function in Older Adults: A Randomized Clinical Trial
Eric J Lenze, Michelle Voegtle, J Philip Miller, et al.
The New England Journal of Medicine
|
November 18, 2015
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Graham R Foster, Nezam Afdhal, Stuart K Roberts, et al.
Gastroenterology
|
April 10, 2017
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Ira M Jacobson, Eric Lawitz, Edward J Gane, et al.
Nature Immunology
|
September 24, 2025
A single-cell and spatial genomics atlas of human skin fibroblasts reveals shared disease-related fibroblast subtypes across tissues
Lloyd Steele, Bayanne Olabi, Kenny Roberts, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 19, 2008
Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat
Mark R Fielden, Alex Nie, Michael McMillian, et al.
The Lancet. Gastroenterology & Hepatology
|
October 8, 2017
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
Alison D Marshall, Evan B Cunningham, Stine Nielsen, et al.
Journal of Parkinson'S Disease
|
May 7, 2026
Practical approaches to inclusive recruitment practices in Parkinson's disease research
Lana M Chahine, Naomi Louie, Elizabeth Disbrow, et al.
Page
of 148
Search research articles
Search
Showing results (1451-1460 of 1,472) with videos related to
Sort By:
Page
of 148
Lancet (London, England)
|
November 27, 2018
Gathering momentum for the way ahead: fifth report of the Lancet Standing Commission on Liver Disease in the UK
Roger Williams, Graeme Alexander, Richard Aspinall, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
September 17, 2025
Association Between Sustained Virological Response and Adverse Liver-related Events in Patients With Decompensated Hepatitis C Virus Cirrhosis
Lisa M van Velsen, Lisette A P Krassenburg, Grishma Hirode, et al.
Biorxiv : the Preprint Server for Biology
|
April 3, 2026
Hidden immune memory niches in inflammatory skin diseases
Lloyd Steele, April R Foster, Kenny Roberts, et al.
JAMA
|
December 13, 2022
Effects of Mindfulness Training and Exercise on Cognitive Function in Older Adults: A Randomized Clinical Trial
Eric J Lenze, Michelle Voegtle, J Philip Miller, et al.
The New England Journal of Medicine
|
November 18, 2015
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Graham R Foster, Nezam Afdhal, Stuart K Roberts, et al.
Gastroenterology
|
April 10, 2017
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials
Ira M Jacobson, Eric Lawitz, Edward J Gane, et al.
Nature Immunology
|
September 24, 2025
A single-cell and spatial genomics atlas of human skin fibroblasts reveals shared disease-related fibroblast subtypes across tissues
Lloyd Steele, Bayanne Olabi, Kenny Roberts, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 19, 2008
Interlaboratory evaluation of genomic signatures for predicting carcinogenicity in the rat
Mark R Fielden, Alex Nie, Michael McMillian, et al.
The Lancet. Gastroenterology & Hepatology
|
October 8, 2017
Restrictions for reimbursement of interferon-free direct-acting antiviral drugs for HCV infection in Europe
Alison D Marshall, Evan B Cunningham, Stine Nielsen, et al.
Journal of Parkinson'S Disease
|
May 7, 2026
Practical approaches to inclusive recruitment practices in Parkinson's disease research
Lana M Chahine, Naomi Louie, Elizabeth Disbrow, et al.
Page
of 148